May 6, 2015 at 3:15pm

New Clinical Nuclear Science Program

Millikin Science
Millikin University has announced a new partnership with Decatur Memorial Hospital (DMH) and Zevacor Molecular to create a Clinical Nuclear Science Program at Millikin University beginning in fall 2015.
The program will provide upper-level biology, chemistry and physics majors at Millikin University with another pathway from being a science student to developing a science career. The program will include formal course work, internships and Performance Learning experiences working with 16 and 70 MeV cyclotrons, and assisting with nuclear medicine programs at both Zevacor Molecular and Decatur Memorial Hospital.
As part of the program, Millikin University will introduce two new courses: Clinical Nuclear Science I, with focus on physics and chemistry, and Clinical Nuclear Science II, with focus on biology. Zevacor Molecular and Decatur Memorial Hospital will provide Millikin students, who are enrolled in the courses, with on-site, short-term practicums and other learning experiences.
In addition, Zevacor Molecular in Noblesville, Ind., will provide funding for a research fellowship in summer 2016, including a $3,000 stipend and a $2,000 housing allowance. Decatur Memorial Hospital will also provide a summer research fellowship, including a $3,000 stipend. Millikin University will provide housing for the student during that summer.
"The Clinical Nuclear Science Program at Millikin University is a unique opportunity for students to help achieve successful science careers," said Dr. David Horn, Millikin associate professor of biology. "By partnering with Decatur Memorial Hospital and Zevacor Molecular, Millikin students will gain a wide range of experiences from the production of nuclear isotopes to examining their use in patients."
The development of a Clinical Nuclear Science Program will be a distinctive feature of the natural and health science programs at Millikin University that complements Millikin's mission of integrating theory and practice through Performance Learning. The partnership will help develop the next generation of scientists and healthcare providers and introduce students to the important field of clinical nuclear science. For more information on the program, call 217.424.6392 or e-mail
Dr. Horn added, "As Illinois Health and Science continues to forge a path as a national leader in nuclear medicine, we look forward to strengthening our partnership and expanding the Performance Learning opportunities Millikin's Clinical Nuclear Science Program can provide."
Millikin President Dr. Patrick White noted, "This new initiative is a result of many months of discussions and site visits, and I want to thank Ken Smithmier, president and chief executive officer of Illinois Health and Science, for his leadership and collaboration on this important project. We are convinced that a clinical nuclear science program involving Zevacor Molecular, Decatur Memorial Hospital and Millikin University will provide significant value to our science students, our respective organizations and our city."
Zevacor Molecular is a healthcare firm that was started by Illinois Health and Science (IHS) in 2013 for the production and distribution of radiopharmaceuticals important in nuclear medicine imaging. For more information, visit
Decatur Memorial Hospital (DMH), located in Decatur, Ill., is a 300 bed, not-for-profit, community hospital that has been providing medical care since 1916 for the residents of central Illinois. Today, DMH has nearly 2,300 dedicated employees and 300 physicians. DMH encompasses 11 state-of-the-art centers of excellence. DMH has been recognized four consecutive years as a 50 Top Cardiovascular Hospital from Truven Health Analytics. For more information, visit
Millikin University is a private, comprehensive university with a diverse student population of approximately 2,200 undergraduate and graduate students. A Millikin education features "Performance Learning," a unique learning approach offering students the chance to build the confidence to succeed before and after graduation.
The Clinical Nuclear Science Program is part of Millikin's Institute for Science Entrepreneurship. The institute's mission is to connect Millikin University, its students, and the greater community to opportunities for personal, professional, and organizational advancement through science entrepreneurship. More information is available at